Uterine perforation – 5-year experience in 3-D image guided gynaecological brachytherapy at Institute of Oncology Ljubljana
By: Barbara Segedin, Jasenka Gugic and Primoz Petric
Open Access
|May 2013References
- 1. Kim RY, Levy DS, Brascho DJ, Hatch KD. Uterine perforation during intracavitary application. Prognostic significance in carcinoma of the cervix.1983;249-51.
- 2. Corn BW, Shaktman BD, Lanciano RM, Hogan WM, Cater JR, Anderson L, et al. Intra- and perioperative complications associated with tandem and colpostat application for cervix cancer.1997;224-9.
- 3. Jhingran A, Eifel PJ. Perioperative and postoperative complications of intracavitary radiation for FIGO stage I-III carcinoma of the cervix.2000;1177-83.
- 4. Granai CO, Doherty F, Allee P, Ball HG, Madoc-Jones H, Curry SL. Ultrasound for diagnosing and preventing malplacement of intrauterine tandems.1990;110-3.
- 5. Matsuyama T, Tsukamoto N, Matsukuma K, Kamura T, Jingu K. Uterine perforation at the time of brachytherapy for the carcinoma of the uterine cervix.1986;205-11.
- 6. Barnes EA, Thomas G, Ackerman I, Barbera L, Letourneau, Lam K, et al. Prospective comparison of clinical and computed tomography assessment in detecting uterine perforation with intracavitary brachytherapy for carcinoma of the cervix.2007;821-6.
- 7. Irvin W, Rice L, Taylor P, Anderson W, Schneider B. Uterine perforation at the time of brachytherapy for carcinoma of the cervix.2003;113-22.
- 8. Milman RM, Goodman P. Uterine perforation by an intracavitary tandem: CT demonstration.1991;223-6.
- 9. Mills SE, Sugg NK, Mahnesmith RC. Endometrial carcinoma with pelvic involvement following uterine perforation.1981;149-54.
- 10. Corn BW, Hanlon AL, Pajak TF, Owen J, Hanks GE. Technically accurate intracavitary insertions improve pelvic control among patients with locally advanced carcinoma of the uterine cervix.1994;294-300.
- 11. Petric P, Hudej R, Marolt-Music M. MRI-based brachytherapy for cervical cancer.2008;46-51.
- 12. Petric P. Moving from 2D to 3D brachytherapy in gynecological tumors.2011;161-2.
- 13. Petric P, Hudej R, Segedin B, Zobec Logar HB. MRI assisted treatment planning improves the DVH parameters in cervix cancer brachytherapy.2011;264-5.
- 14. Petric P, Hudej R, Rogelj P, Blas M, Segedin B, Zobec Logar HB, et al.
- Comparison of 3D MRI with high sampling efficiency and 2D multiplanar MRI for contouring in cervix cancer brachytherapy.2012; 46:242-51.
- 15. Petric P, Dimopoulos JCA, Kirisits C, Berger D, Hudej R, Pötter R. Inter- and intraobserver variation in HR-CTV contouring: intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy.2008;164-71.
- 16. Haie-Meder C, Pötter R, Van Limbergen E, Briot EDe Brabandere MDimopoulos JCAet al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV.2005;235-45.
- 17. Pötter R, Haie-Mader C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.2006;67-77.
- 18. Petric P, Pötter R, Van Limbergen E, Haie-Meder C. Adaptive contouring of the target volume and organs at risk. In: Viswanathan AN, Kristis C, Erickson BE, Pötter R, editors.. Berlin Heidelberg: Springer Verlag; 2011. p. 99-118.
- 19. Gerbaulet A, Pötter R, Haie-Meder C. Cervix cancer. In: Gerbaulet A, Pötter R, Mazeron JJ, Meertens H, Van Limbergen E, editors.. Brussels: European Society of Therapeutic Radiology and Oncology; 2002. p. 301-63.
- 20. Petric P, Hudej R, Marolt-Music M. MRI assisted cervix cancer brachytherapy pre-planning, based on insertion of the applicator in para-cervical anaesthesia: preliminary results of a prospective study.2009;163-9.
- 21. Dimopoulos JCA, Kirisits C, Petric P, Georg P, Lang S, Berger D, et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results.2006;83-90.
- 22. Petric P, Hudej R, Rogelj P, Lindegaard J, Tanderup K, Kirisits C, et al. Frequency-distribution mapping of HR CTV in cervix cancer: possibilities and limitations of existent and prototype applicators.2010;70
- 23. Makin WP, Hunter, RD. CT scanning in intracavitary therapy: Unexpected findings in “straightforward” insertions.1988;253-5.
- 24. Davidson MTM, Yuen J, D’Souza DP, Radwan JS, Hammond JA, Batchelar DL. Optimization of high-dose-rate cervix brachytherapy applicator placement: The benefits of intraoperative ultrasound guidance.2008;248-53.
- 25. Brascho DJ. Use of pelvic pneumography in planning radiotherapy of endometrial carcinoma.1970;113-20.
- 26. Scott WP. Tandem hysterography during intrauterine radium application.1975;636-7.
- 27. Pötter R, Dimopoulos J, Georg P, Lang S, Waldhäusl C, Wachter-Gerstner N, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.2007;148-55.
- 28. Haie-Meder C, Chargari C, Rey A, Dumas I, Morice P, Magné N. MRI-based low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy.2010;161-5.
- 29. De Brabandere M, Mousa AG, Nulens A, Swinnen A, Van Limbergen E. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma.2008;217-26.
- 30. Lindegaard JC, Tanderup K, Nielsen SK, Haack S, Gelineck J. MRI-guided 3D optimization significantly pmproves DVH Parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer.2008;756-64.
- 31. Pötter R, Georg P, Dimopoulos J, Grimm M, Berger D, Nesvacil N, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer.2011;116-23.
- 32. Jürgenliemk-Schulz IM, Tersteeg RJ, Roesink JM, Bijmolt S, Nomden CN, Moerland MA, et al. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer.2009;322-30.
- 33. Granai CO, Allee P, Doherty F, Madoc-Jones H, Curry SL. Ultrasound used for assessing the in situ position of intrauterine tandems.1984;334-8.
- 34. Granai CO, Allee P, Doherty F, Ball HG, Madoc-Jones H, Curry SL. Intraperative real-time ultrasonography during intrauterine tandem placement.1986;112-4.
- 35. Wong F, Bhimji S. The usefulness of ultrasonography in intracavitary radiotherapy using selectron applicators.1990;477-82.
- 36. Tanaka S, Hishikawa Y, Kamikonya N, Miura T. Sonographic positioning of endouterine applicator.1987;92-3.
- 37. Fleischer AC, Burnett LS, Murray MJ, Jones HW. Intraoperative guidance for intrauterine procedures with transrectal sonography.1990;576-7.
- 38. Sharma DN, Rath GK, Thulkar S, Kumar S, Subramani V, Julka PK. Use of transrectal ultrasound for high dose rate interstitial brachytherapy for patients of carcinoma of uterine cervix.2010;12-7.
Language: English
Page range: 154 - 160
Published on: May 21, 2013
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2013 Barbara Segedin, Jasenka Gugic, Primoz Petric, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.